Furthermore, a higher FoxP3+ T-lymphocyte tumor infiltration score has been proven to be a favorable prognostic factor in patients with colon cancer undergoing chemotherapy or chemoimmunotherapy [22]. This evidence concerns the gene FOXP3 and malignant colon neoplasm.